Evidence for a critical role of the sympathetic nervous system in hypertension

Journal of the American Society of Hypertension

Volumn 10, Issue 5, 2016, Pages 457-466

  Grassi, Guido ^a,b   Ram, Venkata S ^c,d  

^a SAN GERARDO HOSPITAL   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

^c APOLLO HOSPITAL   (India)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Cardiovascular risk; genetics; hypertension; sympathetic activity; target organ damage

Indexed keywords

ANTIHYPERTENSIVE AGENT; DOPAMINE; EPINEPHRINE;

ADRENERGIC SYSTEM; ANTIHYPERTENSIVE THERAPY; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE REGULATION; CHEMORECEPTOR REFLEX; CLINICAL TRIAL (TOPIC); DISEASE COURSE; HUMAN; HYPERTENSION; META ANALYSIS (TOPIC); NONHUMAN; PARASYMPATHETIC FUNCTION; PATHOGENESIS; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; REVIEW; SYMPATHETIC TONE; BLOOD PRESSURE; CATHETER ABLATION; COMPLICATION; DRUG EFFECTS; HEART; HEART RATE; INNERVATION; KIDNEY; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SURGERY; SYMPATHECTOMY;

BAROREFLEX; BLOOD PRESSURE; CATHETER ABLATION; DISEASE PROGRESSION; DOPAMINE; EPINEPHRINE; HEART; HEART RATE; HUMANS; HYPERTENSION; KIDNEY; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; STRESS, PSYCHOLOGICAL; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84961911856     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2016.02.015     Document Type: Review

References (58)

1. M.D. Esler The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension Exp Physiol 96 7 2011 611 622
2. G.F. DiBona Sympathetic nervous system and hypertension Hypertension 61 3 2013 556 560
3. G. Grassi, A. Mark, and M. Esler The sympathetic nervous system alterations in human hypertension Circ Res 116 6 2015 976 990
4. P.G. Guyenet The sympathetic control of blood pressure Nat Rev Neurosci 7 5 2006 335 346
5. T.E. Lohmeir, T.M. Dwyer, E.D. Irwin, M.A. Rossing, and R.S. Kieval Prolonged activation of baroreflex abolishes obesity-induced hypertension Hypertension 49 6 2007 1307 1314
6. D.G. Rokosh, and P.C. Simpson Knockout of the α1A/C- adrenergic receptor subtype: the α-1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure Proc Natl Acad Sci U S A 99 14 2002 9474 9479
7. A.J. Chruscinski, D.K. Rohrer, E. Schauble, D. Bernstein, and B.K. Kobika Targeted disruption of the β2 adrenergic receptor gene J Biol Chem 274 24 1999 16694 16700
8. D.K. Rohrer, A. Chruscinski, E.H. Schauble, K.H. Desai, D. Bernstein, and B.K. Kobika Cardiovascular and metabolic alterations in mice lacking both β1- and β2- adrenergic receptors J Biol Chem 274 24 1999 16701 16708
9. P.A. Jose, G.M. Eisner, and R.A. Felder Role of dopamine receptors in the kidney in the regulation of blood pressure Curr Opin Nephrol Hypertens 11 1 2002 87 92
10. U.C. Kopp, and G.F. DiBona Neural regulation of renin secretion Semin Nephrol 13 6 1993 543 551
11. E.J. Johns, U.C. Kopp, and G.F. DiBona Neural control of renal function Compr Physiol 1 2 2011 731 767
12. R. Iliescu, E.D. Irwin, D. Georgakopoulos, and T.E. Lohmeier Renal responses to chronic suppression of central sympathetic outflow Hypertension 60 3 2012 749 756
13. R.A. Dampney, M.J. Coleman, M.A. Fontes, Y. Hirooka, J. Horluchi, Y.W. Li, and et al. Central mechanisms underlying short- and long-term regulation of the cardiovascular system Clin Exp Pharmacol Physiol 29 4 2002 261 268
14. J.W. Osborn Hypothesis: set-points and long-term control of arterial pressure. A theoretical argument for a long-term arterial pressure control system in the brain rather than the kidney Clin Exp Pharmacol Physiol 32 5-6 2005 384 393
15. E.M. Krieger Arterial baroreceptor resetting in hypertension (the JW McCubbin memorial lecture) Clin Exp Pharmacol Physiol 15 suppl 1988 3 17
16. T.N. Thrasher Arterial baroreceptor input contributes to long-term control of blood pressure Curr Hypertens Rep 8 3 2006 249 254
17. T.E. Lohmeier, and R. Iliescu The baroreflex as a long-term controller of arterial pressure Physiology 30 2 2015 148 158
18. S. Julius, A.V. Pascual, and R. London Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension Circulation 44 3 1971 413 418
19. D.S. Goldstein Plasma catecholamines and essential hypertension. An analytical review Hypertension 5 1 1983 86 99
20. M. Esler, G. Lambert, and G. Jennings Regional norepinephrine turnover in human hypertension Clin Exp Hypertens A 11 suppl 1 1989 75 89
21. E.A. Anderson, C.A. Sinkey, W.J. Lawton, and A.L. Mark Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings Hypertension 14 2 1989 177 183
22. R.J. Huggett, J. Burns, A.F. Mackintosh, and D. Mary Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension Hypertension 44 6 2004 847 852
23. G. Grassi, R. Dell'Oro, F. Quarti-Trevano, F. Scopelliti, G. Seravalle, F. Paleari, and et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome Diabetologia 48 7 2005 1359 1365
24. G. Grassi, B.M. Cattaneo, G. Seravalle, A. Lanfranchi, and G. Mancia Baroreflex control of sympathetic nerve activity in essential and secondary hypertension Hypertension 31 1 1998 68 72
25. G. Grassi, G. Seravalle, G. Bertinieri, C. Turri, R. Dell'Oro, M.L. Stella, and et al. Sympathetic and reflex alterations in systodiastolic and systolic hypertension of the elderly J Hypertens 18 5 2000 587 593
26. P.A. Smith, L.N. Graham, A.F. Mackintosh, J.B. Stoker, and D.A.S.G. Mary Sympathetic neural mechanisms in white-coat hypertension J Am Coll Cardiol 40 1 2002 126 132
27. S.A. Neumann, R. Jennings, M.F. Muldoon, and S.B. Manuck White-coat hypertension and autonomic nervous system dysregulation Am J Hypertens 18 5 2005 584 588
28. G. Grassi, G. Seravalle, F.Q. Trevano, R. Dell'Oro, G. Bolla, C. Cuspidi, and et al. Neurogenic abnormalities in masked hypertension Hypertension 50 3 2007 537 542
29. G. Grassi, G. Seravalle, F. Quarti-Trevano, R. Dell'Oro, M. Bombelli, C. Cuspidi, and et al. Adrenergic, metabolic and reflex abnormalities in reverse an extreme dipper hypertensives Hypertension 52 5 2000 925 931
30. J.P. Greenwood, E.M. Scott, J.B. Stoker, and D.A. Mary Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive J Am Coll Cardiol 38 2001 1711 1717
31. M.P. Schlaich, D.M. Kaye, E. Lambert, M. Sommerville, F. Socratous, and M.D. Esler Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy Circulation 108 2003 560 565
32. G. Grassi, G. Seravalle, F. Quarti-Trevano, R. Dell'Oro, F. Arenare, D. Spaziani, and et al. Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction Hypertension 53 2009 205 209
33. R.L. Converse, T.N. Jacobsen, R.D. Toto, C.M. Jost, F. Cosentino, F. Fouad-Tarazi, and et al. Sympathetic overactivity in patients with chronic renal failure N Engl J Med 327 27 1992 1912 1918
34. G. Grassi, F. Quarti-Trevano, G. Seravalle, F. Arenare, M. Volpe, S. Furiani, and et al. Early sympathetic activation in the initial clinical stages of chronic renal failure Hypertension 57 4 2011 846 851
35. J.T. Kielstein, and D. Fliser The past, present and future of ADMA in nephrology Nephrol Ther 3 2 2007 47 54
36. G. Grassi, G. Seravalle, L. Ghiadoni, G. Tripepi, R.M. Bruno, G. Mancia, and et al. Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease Clin J Am Soc Nephrol 6 11 2011 2620 2627
37. G. Mancia, G. Grassi, and C. Borghi Hyperuricemia, urate deposition and the association with hypertension Curr Med Res Opin 31 Suppl 2 2015 15 19
38. B.M. Egan, and S. Stevens-Fabry Prehypertension-prevalence, health risks and management strategies Nat Rev Cardiol 12 5 2015 289 300
39. D. Hering, T. Kara, W. Kucharska, V.K. Somers, and K. Narkiewicz Hig-normal blood pressure is associated with increased resting sympathetic activity but normal responses to stress tests Blood Press 22 3 2013 183 187
40. G. Seravalle, L. Lonati, S. Buzzi, M. Cairo, F. Quarti-Trevano, R. Dell'Oro, and et al. Sympathetic nerve traffic and baroreflex function in optimal, normal and high-normal blood pressure states J Hypertens 33 7 2015 1411 1417
41. G.K. Pal, C. Adithan, T.K. Dutta, D. Amudharaj, P. Pravati, P.G. Nandan, and et al. Assessment of sympathovagal imbalance by spectral analysis of heart rate variability in prehypertensive and hypertensive patients in Indian population Clin Exp Hypertens 338 7 2011 478 483
42. F. Mafhoud, M. Bohm, M. Azizi, A. Patak, I. Durand Zaleski, S. Ewen, and et al. Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design Eur Heart J 36 33 2015 2219 2227
43. G. Grassi, G. Seravalle, G. Brambilla, C. Pini, M. Alimento, R. Facchetti, and et al. Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension Int J Cardiol 177 3 2014 1020 1025
44. C. Vlachopoulos, K. Aznaouridis, M.F. O'Rourke, M.E. Safar, K. Baou, and C. Stefanidis Reduction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis Eur Heart J 31 15 2010 1865 1871
45. J.D. Bisognano, G. Bakris, M.K. Nadim, L. Sanchez, A.A. Kroon, J. Schafer, and et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension J Am Coll Cardiol 58 7 2011 765 773
46. D.L. Bhatt, D.E. Kandzari, W.W. O'Neill, R. D'Agostino, J.M. Flack, B.T. Katzen, and et al. for the SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension N Engl J Med 370 2014 1393 1401
47. G. Grassi, G. Seravalle, G. Brambilla, D. Trabattoni, C. Cuspidi, R. Corso, and et al. Blood pressure responses to renal denervation precede and are independent on the sympathetic and baroreflex effects Hypertension 65 6 2015 1209 1216
48. G. Grassi, C. Turri, R. Dell'Oro, M.L. Stella, G.B. Bolla, and G. Mancia Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of circulation in essential hypertension J Hypertens 16 1998 1789 1796
49. G. Grassi, G. Seravalle, R. Dell'Oro, F. Quarti-Trevano, M. Bombelli, F. Scopelliti, and et al. Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity and sympathetic drive in obese hypertensive individuals: results of the CROSS Study J Hypertens 21 2003 1761 1769
50. G. Seravalle, G. Brambilla, D. Prata Pizzalla, A. Casati, M. Riva, C. Cuspidi, and et al. Differential effects of enalapril-felodipine vs enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension J Am Soc Hypertens 10 2016 244 251
51. A. Zanchetti, G. Grassi, and G. Mancia When should antihypertensive drug treatment be initiated and what levels should systolic blood pressure be lowered? A critical appraisal J Hypertens 27 5 2009 923 934
52. G. Mancia, R. Fagard, K. Narkiewicz, J. Redon, A. Zanchetti, M. Bohm, and et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension J Hypertens 31 7 2013 1281 1357
53. M.H. Alderman, W.L. Ooi, S. Madhavan, and H. Cohen Treatment induced blood pressure reduction and the risk of myocardial infarction JAMA 262 7 1989 920 924
54. G. Grassi, S. Padmanabhan, C. Menni, G. Seravalle, W.K. Lee, M. Bombelli, and et al. Association between ADRA1A gene and the metabolic syndrome: candidate genes and functional counterpart in the PAMELA population J Hypertens 29 6 2011 1121 1127
55. S.J. Nielsen, J. Jeppesen, C. Torp-Pedersen, T.W. Hansen, A. Linneberg, and M. Fenger Tyrosine hydroxylase polymorphism (C-824T) and hypertension: a population-based study Am J Hypertens 23 12 2010 1306 1311
56. K. Masuo, T. katsuya, Y. Fu, H. Rakugi, T. Ogihara, and M.L. Tuck Beta 2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals Am J Hypertens 18 7 2005 1009 1014
57. G. Seravalle, A. Piperno, R. Mariani, I. Pelloni, R. Facchetti, R. Dell'Oro, and et al. Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: a microneurographic study Eur Heart J 37 2016 988 995
58. G. Pongratz, and R.H. Straub The sympathetic nervous response in inflammation Arthritis Res and Ther 16 6 2014 504 526